Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repligen Corp (NASDAQ:RGEN)

Monday’s trading has closed, but RGEN is being traded in the after-hours session. After-Hours quote »
35.48
Delayed Data
As of 3:59pm ET
 +0.47 / +1.34%
Today’s Change
18.23
Today|||52-Week Range
42.48
+79.19%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close35.01
Today’s open34.95
Day’s range34.95 - 36.12
Volume210,296
Average volume (3 months)382,044
Market cap$1.2B
Dividend yield--
Data as of 3:59pm ET, 08/03/2015

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)+32.00%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-6.78%
P/E ratio173.8
Price/Sales10.36
Price/Book10.27

Competitors

 Today’s
change
Today’s
% change
RPTPRaptor Pharmaceutica...+0.49+3.44%
HRTXHeron Therapeutics I...+0.66+2.04%
MACKMerrimack Pharmaceut...+0.18+1.78%
CLLSCellectis SA-0.62-1.73%
Data as of 4:14pm ET, 08/03/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)$0.08
Annual revenue (last year)$63.5M
Annual profit (last year)$8.2M
Net profit margin12.86%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive &
Operating Officer
Tony J. Hunt
Chief Financial Officer
Jon K. Snodgres
Corporate headquarters
Waltham, Massachusetts

Forecasts